1. Home
  2. AVXL vs YSG Comparison

AVXL vs YSG Comparison

Compare AVXL & YSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$3.16

Market Cap

289.1M

Sector

Health Care

ML Signal

HOLD

YSG

Yatsen Holding Limited

HOLD

Current Price

$2.94

Market Cap

267.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVXL
YSG
Founded
2004
2016
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
289.1M
267.5M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
AVXL
YSG
Price
$3.16
$2.94
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$22.00
N/A
AVG Volume (30 Days)
852.5K
97.0K
Earning Date
05-08-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$23.08
Revenue Next Year
N/A
$9.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.61
$2.64
52 Week High
$13.99
$11.04

Technical Indicators

Market Signals
Indicator
AVXL
YSG
Relative Strength Index (RSI) 40.94 42.97
Support Level $2.93 $2.87
Resistance Level $3.76 $3.36
Average True Range (ATR) 0.19 0.19
MACD 0.01 0.02
Stochastic Oscillator 12.23 41.67

Price Performance

Historical Comparison
AVXL
YSG

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

About YSG Yatsen Holding Limited

Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands.

Share on Social Networks: